心脏风险6级:预测急诊室的短期严重结果 急性心力衰竭患者
Ian G Stiell1, Jeffrey J Perry1, Debra Eagles1
1Department of Emergency Medicine, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada.
JACC. Advances
|August 12, 2024
概括
一个新的HEARTRISK6尺度有助于预测急性心力衰竭 (AHF) 患者向急诊室 (ED) 提交的严重结果. 该工具有助于在AHF案件中做出更安全,更有效的处置决策.
科学领域:
- 心脏病学 心脏病学
- 紧急医疗 紧急医疗
- 临床风险分层的临床风险分层
背景情况:
- 急性心力衰竭 (AHF) 是一个频繁的急诊室 (ED) 呈现,结果各不相同.
- 目前指导AHF患者处置决策的证据有限.
- 许多AHF患者不需要住院治疗,因此需要准确的风险评估.
研究的目的:
- 开发和验证一种风险评分,用于预测AHF患者的短期严重结果 (SSO).
- 为临床医生提供一个工具,以改善有关患者处置的决策.
主要方法:
- 汇集了来自三个潜在队列的数据,其中包括来自10个三级护理ED的2,246名AHF患者.
- 定义SSO为30天内死亡,输管或非侵入性通风 (NIV),心肌梗塞或ED复发14天内.
- 使用了13个预测因素的后勤回归和基于AIC的逐步下降选择,然后进行内部验证.
主要成果:
- 心脏风险6尺度确定了六个关键预测因素:膜心脏病,心动减速,需要NIV,肌素,热素,以及未能重新评估 (步行测试).
- 该尺度在预测SSO方面表现出良好的灵敏度,门为88.3%和71.5%的灵敏度.
- 12.5%的患者经历了SSO,包括死亡,显著比例发生在出院患者中.
结论:
- 心脏风险6级是一个简洁而敏感的工具,用于评估AHF患者的短期严重结果.
- 这种规模的实施可以提高ED处置决策的安全性和效率.
- 这个风险评分解决了AHF演示的指导管理中的一个关键缺口.
更多相关视频
相关概念视频
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Heart Failure Drugs: β-Blockers
326
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
326
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
406
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
406
Imaging Studies for Cardiovascular System I:Echocardiography
306
Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
306


